28. 全身性アミロイドーシス Systemic amyloidosis Clinical trials / Disease details

臨床試験数 : 267 / 薬物数 : 241 - (DrugBank : 77) / 標的遺伝子数 : 68 - 標的パスウェイ数 : 180

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03315026 (ClinicalTrials.gov)	December 14, 2017	13/10/2017	Siltuximabto Decrease Symptom Burden After Autologous Stem Cell Transplantation for Patients With Mu ...	Phase II Study of Interleukin 6 Blockade With Siltuximabto Decrease Symptom Burden in Patients Age 6 ...	Multiple Myeloma;AL Amyloidosis	Drug: Siltuximab;Behavioral: The M.D. Anderson Symptom Inventory (MDASI)	Memorial Sloan Kettering Cancer Center	Janssen Scientific Affairs, LLC	Active, not recruiting	60 Years	75 Years	All	30	Phase 2	United States

First Previous1Next Last